Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1

Patrick Sheets, Garold S. Yost, Gary P. Carlson

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Benzene is an occupational and environmental toxicant. The main human health concern associated with benzene exposure is leukemia. The toxic effects of benzene are dependent on its metabolism by the cytochrome P450 enzyme system. The cytochrome P450 enzymes CYP2E1 and CYP2F2 are the major contributors to the bioactivation of benzene in rats and mice. Although benzene metabolism has been shown to occur with mouse and human lung microsomal preparations, little is known about the ability of human CYP2F to metabolize benzene or the lung cell types that might activate this toxicant. Our studies compared bronchiolar derived (BEAS-2B) and alveolar derived (A549) human cell lines for benzene metabolizing ability by evaluating the roles of CYP2E1 and CYP2F1. BEAS-2B cells that overexpressed CYP2F1 and recombinant CYP2F1 were also evaluated. BEAS-2B cells overexpressing the enzyme CYP2F1 produced 47.4 ± 14.7 pmols hydroxylated metabolite/106 cells/45 min. The use of the CYP2E1-selective inhibitor diethyldithiocarbamate and the CYP2F2-selective inhibitor 5-phenyl-1-pentyne demonstrated that both CYP2E1 and CYP2F1 are important in benzene metabolism in the BEAS-2B and A549 human lung cell lines. The recombinant expressed human CYP2F1 enzyme had a Km value of 3.83 μM and a Vmax value of 0.01 pmol/pmol P450 enzyme/min demonstrating a reasonably efficient catalysis of benzene metabolism (Vmax/Km = 2.6). Thus, these studies have demonstrated in human lung cell lines that benzene is bioactivated by two lung-expressed P450 enzymes.

Original languageEnglish (US)
Pages (from-to)92-99
Number of pages8
JournalJournal of Biochemical and Molecular Toxicology
Volume18
Issue number2
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Benzene
Metabolism
Cells
Cell Line
Lung
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP2E1
A549 Cells
Ditiocarb
Poisons
Enzymes
Metabolites
Catalysis
Rats
Leukemia
Health

Keywords

  • Benzene
  • Cytochromes P450
  • Liver
  • Lung

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. / Sheets, Patrick; Yost, Garold S.; Carlson, Gary P.

In: Journal of Biochemical and Molecular Toxicology, Vol. 18, No. 2, 2004, p. 92-99.

Research output: Contribution to journalArticle

@article{ac1d7b024ddb4992a6045a649aeadebf,
title = "Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1",
abstract = "Benzene is an occupational and environmental toxicant. The main human health concern associated with benzene exposure is leukemia. The toxic effects of benzene are dependent on its metabolism by the cytochrome P450 enzyme system. The cytochrome P450 enzymes CYP2E1 and CYP2F2 are the major contributors to the bioactivation of benzene in rats and mice. Although benzene metabolism has been shown to occur with mouse and human lung microsomal preparations, little is known about the ability of human CYP2F to metabolize benzene or the lung cell types that might activate this toxicant. Our studies compared bronchiolar derived (BEAS-2B) and alveolar derived (A549) human cell lines for benzene metabolizing ability by evaluating the roles of CYP2E1 and CYP2F1. BEAS-2B cells that overexpressed CYP2F1 and recombinant CYP2F1 were also evaluated. BEAS-2B cells overexpressing the enzyme CYP2F1 produced 47.4 ± 14.7 pmols hydroxylated metabolite/106 cells/45 min. The use of the CYP2E1-selective inhibitor diethyldithiocarbamate and the CYP2F2-selective inhibitor 5-phenyl-1-pentyne demonstrated that both CYP2E1 and CYP2F1 are important in benzene metabolism in the BEAS-2B and A549 human lung cell lines. The recombinant expressed human CYP2F1 enzyme had a Km value of 3.83 μM and a Vmax value of 0.01 pmol/pmol P450 enzyme/min demonstrating a reasonably efficient catalysis of benzene metabolism (Vmax/Km = 2.6). Thus, these studies have demonstrated in human lung cell lines that benzene is bioactivated by two lung-expressed P450 enzymes.",
keywords = "Benzene, Cytochromes P450, Liver, Lung",
author = "Patrick Sheets and Yost, {Garold S.} and Carlson, {Gary P.}",
year = "2004",
doi = "10.1002/jbt.20010",
language = "English (US)",
volume = "18",
pages = "92--99",
journal = "Journal of Biochemical and Molecular Toxicology",
issn = "1095-6670",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1

AU - Sheets, Patrick

AU - Yost, Garold S.

AU - Carlson, Gary P.

PY - 2004

Y1 - 2004

N2 - Benzene is an occupational and environmental toxicant. The main human health concern associated with benzene exposure is leukemia. The toxic effects of benzene are dependent on its metabolism by the cytochrome P450 enzyme system. The cytochrome P450 enzymes CYP2E1 and CYP2F2 are the major contributors to the bioactivation of benzene in rats and mice. Although benzene metabolism has been shown to occur with mouse and human lung microsomal preparations, little is known about the ability of human CYP2F to metabolize benzene or the lung cell types that might activate this toxicant. Our studies compared bronchiolar derived (BEAS-2B) and alveolar derived (A549) human cell lines for benzene metabolizing ability by evaluating the roles of CYP2E1 and CYP2F1. BEAS-2B cells that overexpressed CYP2F1 and recombinant CYP2F1 were also evaluated. BEAS-2B cells overexpressing the enzyme CYP2F1 produced 47.4 ± 14.7 pmols hydroxylated metabolite/106 cells/45 min. The use of the CYP2E1-selective inhibitor diethyldithiocarbamate and the CYP2F2-selective inhibitor 5-phenyl-1-pentyne demonstrated that both CYP2E1 and CYP2F1 are important in benzene metabolism in the BEAS-2B and A549 human lung cell lines. The recombinant expressed human CYP2F1 enzyme had a Km value of 3.83 μM and a Vmax value of 0.01 pmol/pmol P450 enzyme/min demonstrating a reasonably efficient catalysis of benzene metabolism (Vmax/Km = 2.6). Thus, these studies have demonstrated in human lung cell lines that benzene is bioactivated by two lung-expressed P450 enzymes.

AB - Benzene is an occupational and environmental toxicant. The main human health concern associated with benzene exposure is leukemia. The toxic effects of benzene are dependent on its metabolism by the cytochrome P450 enzyme system. The cytochrome P450 enzymes CYP2E1 and CYP2F2 are the major contributors to the bioactivation of benzene in rats and mice. Although benzene metabolism has been shown to occur with mouse and human lung microsomal preparations, little is known about the ability of human CYP2F to metabolize benzene or the lung cell types that might activate this toxicant. Our studies compared bronchiolar derived (BEAS-2B) and alveolar derived (A549) human cell lines for benzene metabolizing ability by evaluating the roles of CYP2E1 and CYP2F1. BEAS-2B cells that overexpressed CYP2F1 and recombinant CYP2F1 were also evaluated. BEAS-2B cells overexpressing the enzyme CYP2F1 produced 47.4 ± 14.7 pmols hydroxylated metabolite/106 cells/45 min. The use of the CYP2E1-selective inhibitor diethyldithiocarbamate and the CYP2F2-selective inhibitor 5-phenyl-1-pentyne demonstrated that both CYP2E1 and CYP2F1 are important in benzene metabolism in the BEAS-2B and A549 human lung cell lines. The recombinant expressed human CYP2F1 enzyme had a Km value of 3.83 μM and a Vmax value of 0.01 pmol/pmol P450 enzyme/min demonstrating a reasonably efficient catalysis of benzene metabolism (Vmax/Km = 2.6). Thus, these studies have demonstrated in human lung cell lines that benzene is bioactivated by two lung-expressed P450 enzymes.

KW - Benzene

KW - Cytochromes P450

KW - Liver

KW - Lung

UR - http://www.scopus.com/inward/record.url?scp=2342663701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342663701&partnerID=8YFLogxK

U2 - 10.1002/jbt.20010

DO - 10.1002/jbt.20010

M3 - Article

C2 - 15122651

AN - SCOPUS:2342663701

VL - 18

SP - 92

EP - 99

JO - Journal of Biochemical and Molecular Toxicology

JF - Journal of Biochemical and Molecular Toxicology

SN - 1095-6670

IS - 2

ER -